Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA35 for Chronic Wounds and Pain
NCT05810649Completed
- Sponsor
- Nakhia Impex LLC
- Start
- Apr 2023
- Primary completion
- Aug 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of ha35 in Chronic wound and pain, sponsored by Nakhia Impex LLC. Primary endpoints: Wound-associated pain measurement at 24 hours, Measurement of darkness or redness of the skin surrounding the wounds at 10 days and 3 more. Started Apr 2023; status: completed.
02
Drugs
ha35
03
Conditions
Chronic woundpain
Beyond the preview
Go deeper on NCT05810649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05810649.